SlideShare une entreprise Scribd logo
1  sur  28
Pulmmonary Tuberculosis
Causative agent (P.T.)
• : Mycobacterium tuberculosis
• Was an important cause of death prior
  the antibiotic era
• Currently its importance rising again
  due to - AIDS
•         - multidrug resistance
Etiology and Pathogenesis (PT)
• M. tuberculosis: transmitted by
  infective droplets
• M. bovis: milk diseased cow
• M. avium      :  avirulent to normal
  subjects
• M. intracellulare:    disseminated
  infection in 15-24% AIDS patients
Pathogenesis
•   Mycobacterium - has no known
    exotoxin, endotoxin, proteolytic
    enzyme
• Pathogenecity of M. tubeculosa is
    related to ability to:
1. escape killing by macrophages
2. induce delayed hypersensitivity
Pathogenesis
•    Induction of delayed hypersensitivity by P.T.
     attributed to several components of M.
     tubersulosa cell wall:
1. cord factor: surface glycolipid, facilitates cultured
     mycobacter to grow in cords.
                             a.
     Pathogenic mycobacter: cord factor positive,
     Non-pathogenic: cord factor negative:
Injection purified cord factor in mice ⇒ granuloma
     formation
2. Lipoarabimannam (LAM): heteropolysaccharide
     similar to endotoxin in gram negative bacteria.
Pathogenesis
LAM      a. - inhibits macrophage
 activation by interferon-γ
  – b. induces macrophages to secrete TNF-α
    (fever, weight loss, tissue damage)
    c. induces macrophages to secrete
 IL-10 suppresses mycobacteria-nduced
 T-cell proliferation)
Pathogenesis
•    iii. Complement -activated on surface of
     mycobacteria may opsonise mycobacteria
     ⇒ macrophage complement receptor (CR3)
     (Mac-1 integrin) without triggering the
     respiratory burst necessary to kill the
     bacteria.
iv. Highly immunogenic Tuberculous heat-
     shock protein is similar to human ⇒
     autoimmune reactions induced by
     mycobacteria.
Pathogenesis
• Mycobacter resides in phagosomes which
  are not acidified into lysosomes.
• Inhibition of acidification is associated with
  urease secreted by mycobacter.
• The development of cell-mediated, type IV,
  hypersensitivity to the mycobacteria explains
  the organism’s destructiveness in tissues
  and also the emergence of resistance the
  mycroorganism.
Pathogenesis
• Initial exposure to the M. tuberculosa
  ⇒ no-specific inflammatory reaction
• After 2-3 weeks: reaction changes to
  granulomatous, center caseates
• The patteren of host response depends
  on whether the infection is a primary
  exposure (primary) or it is in a
  sensitized host (secondary).
Primary Tuberculosis
• Disease acquired from initial exposure
  to M. tuberculosa
• Inhaled microorganisms multiply in
  alveoli, alveolar macrophages can not
  readily kill the bacteria.
• Naïve macrophages can not kill
  mycobacteria ⇒ multiply, lyse the cell
  ⇒ infect other macrophages, spread by
  the blood stream.
Pathogenesis
• After a few weeks (2-3) ⇒ development T-
  cell-mediated immunity.
• Mycobacteria-activated T-cells react with
  macrophages through following ways:
• 1. CD4+ helper T-cells secrete interferon-γ
• interferon-γ ⇒ activates macrophages ⇒
  killing of intracellular mycobacteria
2. mycobacter through intermediate nitrogen
  species.
∀ ⇒ epithelioid granuloma formation
Pathogenesis
2. CD8+ suppressor T cells ⇒ lyse
    macrophages infected with
    mycobacter through Fas-independent
    pathway.
3. CD4-, CD8- (double-negative) T –cells
    lyse macrophages by Fas-dependent
    pathway, without killing
    mycobacteria.
Pathogenesis
       primary tuberculosis
• Mycobacteria can not grow in acidic
     extracellular environment
•    ⇒infection is controlled.
• Fate of primary tuberculosis:
     calcification
The Ghon Complex:
• first lesion of primary tuberculosis
• G.C. consists of - peripheral
  parenchymal granuloma (often located
  in lower lobes) (Ghon nodule)
• a prominent infected mediastinal (hilar)
  lymphnode
• lymphangitis joining nodule to hilar L.
  node
Grossly: Ghon nodule: 1-2 cm ∅
Pathogenesis
• Histo: Granuloma, central caseous necrosis.
• Clinically: Usualy assymptomatic, localized
  lesions⇒ healing (`~90% cases).

• In occasional cases, however, primary tb
•          - spreads to other parts of the lung
  (progressive primary TB)
  common in children,
  immunocompromised adults
Pathogenesis
• Gross: primary lesion enlarges to
  lesions ~6 cm ∅ ⇒ cavities occupying
  most of lower lobes
Secondary TB

• This stage results from:
•    - reactivation of primary pulmonary TB
• new infection in a previously sensitized
  individual
• This stage results from:
•    - reactivation of primary pulmonary TB
• new infection in a previously sensitized
  individual
• new infection in a previously sensitized
  individual
• Initial response to M. tuberculosa is
  different in patients with secondary TB.
• Infection ⇒ latent period⇒ cellular
  immune response ⇒formation of many
  granulomas , extensive tissue necrosis
• Apical and posterior segments upper
  lobes most commonly affected
Histology tuberculous granuloma
• Gross: Diffuse fibrotic lesions, with
  caseative necrosis
•         ⇒ heal and calcify
•         ⇒ erosion of
  bronchi⇒drainage caseous material
  and infectious agents⇒ tuberculous
  cavity
Tuberculous Cavities
• Size: 1- 10 cm
• Location: apices of upper lobes
•    Wall of cavity consists fibrotic
  material with granulation tissue
•    Cavity: caseous material with bacilli
•         On healing: fibrosis with
  calcifications
Complications of secondary
         tuberculosis
1. milliary TB: presence of multiple, small
    (size of millet seeds)
•    granulomas in many organs.
• Spread usually haematogenous,
    mostly from primary pulmonary Tb or
    from other sites
2.Hemopthysis: Bleeding from eroded
    blood vessel in cavity
∀ ⇒ Drowning into one’s own blood.
Complication tuberculous
           granuloma
3. Bronchopleural fistula: rupture of
    subpleural cavity ⇒ pleural
• space ⇒ tuberculous empyema ⇒
    pneumothorax
4. Intestinal tuberculosis: follows
    swallowing of tuberculous
•    material
M.tuberculosis and M. avium
  intracellulare lesions in AIDS
• Mycobacterial infection in AIDS can take
  three forms depending on degree of
  immunosuppression
• 1. In developing countries where M.
  tuberculosis is frequent: HIV infected
  individuals have primary and secondary M.
  tuberculosis infection with the usual well
  formed granulomas, composed of epithelioid
  cells, Langerhan’s giant cells and
  lymphocytes. In these granulomas acid-fast
  bacilli are few and difficult to find.
tuberculosis in AIDS
2. When HIV patients develop AIDS and
   are moderately immunocompressed
   (< 200 CD4+ T helper
   lymphocytes/ml): infection is mostly
   from reactivation/re-infection.
   Because mycobacteria infect T-cells
   and macrophages, defects in the host
   immune response to M. tuberculosis
   may be;
tuberculosis in AIDS
a. secondary to the failure of CD4 helper
   T-lymphocytes to secrete
   lymphokines that activate
   macrophages to kill bacteria
b. failure of infected helper T-
   lymphocytes to secrete and
   mycobacteria infected macrophages
   to respond to lymphokines.
tuberculosis in AIDS
• The relative increase in number of CD8+
  cytotoxic T-lymphocytes to cause
  macrophage destruction in the M.
  tuberculosa lesions.
•     ⇒ histologically: granulomas less well
  formed, are more frequent necrotic, and
  contain more abundant acid fast bacilli.
• Though sputum is positive for mycobacteria
  in 31-83% of AIDS patients , only 33% react
  with PPD.
tuberculosis in AIDS
•   extrapulmonary TB occurs in 70% cases
    involving LN, blood, CNS, and GIT.
•   3. Opportunistic infection with M. avium
    intracellulare (occurs in severely
    immunocompromised patients: < 60 CD+ T-
    lymphocytes) Most organisms originate
    from GIT though some from RT
•   Infection usually widely disseminated
    throughout the reticulo-endothelial system
    ⇒ enlargement of lymphnodes
tuberculosis in AIDS
• There is a large number of
  mycobacteria in the enlarged nodes.
• Granulomas, lymphocytes and tissue
  destruction are rare

Contenu connexe

Tendances

Tendances (20)

Tuberclosis
TuberclosisTuberclosis
Tuberclosis
 
Infectious Diseases 12
Infectious Diseases  12Infectious Diseases  12
Infectious Diseases 12
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis harindu
Tuberculosis harinduTuberculosis harindu
Tuberculosis harindu
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
pulmonary tuberculosis
pulmonary tuberculosispulmonary tuberculosis
pulmonary tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Infectious Disease
Infectious DiseaseInfectious Disease
Infectious Disease
 
Tuberculosis- Oral Pathology
Tuberculosis- Oral PathologyTuberculosis- Oral Pathology
Tuberculosis- Oral Pathology
 
Mycobacterial diseases
Mycobacterial diseasesMycobacterial diseases
Mycobacterial diseases
 
Mycobacterium tuberculosis
Mycobacterium tuberculosisMycobacterium tuberculosis
Mycobacterium tuberculosis
 
Jai cmb
Jai cmbJai cmb
Jai cmb
 
Primary tb by arif khan
Primary tb by arif khanPrimary tb by arif khan
Primary tb by arif khan
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Pulmonary tb lec &amp; practical
Pulmonary tb lec &amp; practical Pulmonary tb lec &amp; practical
Pulmonary tb lec &amp; practical
 
ATYPICAL MYCOBACTERIA
ATYPICAL MYCOBACTERIAATYPICAL MYCOBACTERIA
ATYPICAL MYCOBACTERIA
 
Pulmonary tb lec
Pulmonary tb lec Pulmonary tb lec
Pulmonary tb lec
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 

En vedette

Tuberculosis presentation by Sohel Memon
Tuberculosis presentation by Sohel MemonTuberculosis presentation by Sohel Memon
Tuberculosis presentation by Sohel MemonDr.Sohel Memon
 
Pulmonary Tuberculosis
Pulmonary TuberculosisPulmonary Tuberculosis
Pulmonary Tuberculosisghalan
 
Review on microbiology and pathophysiology of tuberculosis
Review on microbiology and pathophysiology of tuberculosisReview on microbiology and pathophysiology of tuberculosis
Review on microbiology and pathophysiology of tuberculosisdocpiash
 
Tuberculosis Pathogenesis
Tuberculosis PathogenesisTuberculosis Pathogenesis
Tuberculosis PathogenesisDr Hemanth Naik
 
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzahkciapm
 
Tuberculosis1
Tuberculosis1Tuberculosis1
Tuberculosis1Deep Deep
 
Bacterial infections
Bacterial infectionsBacterial infections
Bacterial infectionsAbakash Deo
 
Mycobacterium tuberculosis and atypical mycobacteria
Mycobacterium tuberculosis and atypical mycobacteriaMycobacterium tuberculosis and atypical mycobacteria
Mycobacterium tuberculosis and atypical mycobacteriaYahya Noori, Ph.D
 
Pulmonary Tuberculosis Presentation
Pulmonary Tuberculosis PresentationPulmonary Tuberculosis Presentation
Pulmonary Tuberculosis PresentationJack Frost
 
periodontal instruments and their uses
periodontal instruments and their uses periodontal instruments and their uses
periodontal instruments and their uses Zara dentist
 
Pulmonary Tuberculosis
Pulmonary Tuberculosis Pulmonary Tuberculosis
Pulmonary Tuberculosis Hamdi Turkey
 
Intra oral examination
Intra oral examinationIntra oral examination
Intra oral examinationOzident
 

En vedette (17)

Tuberculosis presentation by Sohel Memon
Tuberculosis presentation by Sohel MemonTuberculosis presentation by Sohel Memon
Tuberculosis presentation by Sohel Memon
 
Pulmonary Tuberculosis
Pulmonary TuberculosisPulmonary Tuberculosis
Pulmonary Tuberculosis
 
Review on microbiology and pathophysiology of tuberculosis
Review on microbiology and pathophysiology of tuberculosisReview on microbiology and pathophysiology of tuberculosis
Review on microbiology and pathophysiology of tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis Pathogenesis
Tuberculosis PathogenesisTuberculosis Pathogenesis
Tuberculosis Pathogenesis
 
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzah
 
Tuberculosis1
Tuberculosis1Tuberculosis1
Tuberculosis1
 
Chronic granulomatous inflammation
Chronic granulomatous inflammationChronic granulomatous inflammation
Chronic granulomatous inflammation
 
Bacterial infections
Bacterial infectionsBacterial infections
Bacterial infections
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Mycobacterium tuberculosis and atypical mycobacteria
Mycobacterium tuberculosis and atypical mycobacteriaMycobacterium tuberculosis and atypical mycobacteria
Mycobacterium tuberculosis and atypical mycobacteria
 
Pulmonary Tuberculosis Presentation
Pulmonary Tuberculosis PresentationPulmonary Tuberculosis Presentation
Pulmonary Tuberculosis Presentation
 
periodontal instruments and their uses
periodontal instruments and their uses periodontal instruments and their uses
periodontal instruments and their uses
 
Pulmonary Tuberculosis
Pulmonary Tuberculosis Pulmonary Tuberculosis
Pulmonary Tuberculosis
 
Intra oral examination
Intra oral examinationIntra oral examination
Intra oral examination
 
Periodontal instruments
Periodontal  instrumentsPeriodontal  instruments
Periodontal instruments
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 

Similaire à Pulmmonary tuberculosis

Lec 3 tuberculosis 3
Lec 3 tuberculosis 3Lec 3 tuberculosis 3
Lec 3 tuberculosis 3DOCTOR WHO
 
Pathophysiology tubercuslosis
Pathophysiology tubercuslosisPathophysiology tubercuslosis
Pathophysiology tubercuslosisNem kumar Jain
 
Mycobacterium Tuberculosis
Mycobacterium TuberculosisMycobacterium Tuberculosis
Mycobacterium TuberculosisMohsin Javed
 
TUBERCULOSIS pharmacology notes types cure
TUBERCULOSIS pharmacology notes types cureTUBERCULOSIS pharmacology notes types cure
TUBERCULOSIS pharmacology notes types cureAffrin Shaik
 
Pathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosisPathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosisSoujanya Pharm.D
 
Immunity against microbial infections dr.ihsan alsaimary
Immunity against microbial infections dr.ihsan alsaimaryImmunity against microbial infections dr.ihsan alsaimary
Immunity against microbial infections dr.ihsan alsaimarydr.Ihsan alsaimary
 
TUBERCOLOSIS and Primary infections.pptx
TUBERCOLOSIS and Primary infections.pptxTUBERCOLOSIS and Primary infections.pptx
TUBERCOLOSIS and Primary infections.pptxNastehomohamedmuqtaa
 
1. mycobacterial infection tuberculosis- dr. sinhasan, mdzah
1. mycobacterial infection tuberculosis- dr. sinhasan, mdzah1. mycobacterial infection tuberculosis- dr. sinhasan, mdzah
1. mycobacterial infection tuberculosis- dr. sinhasan, mdzahkciapm
 
Mycobacterium Tuberculosis
Mycobacterium TuberculosisMycobacterium Tuberculosis
Mycobacterium TuberculosisMary Mwinga
 
Kampala International University PULMONARY TUBERCULOSIS.pptx
Kampala International University PULMONARY TUBERCULOSIS.pptxKampala International University PULMONARY TUBERCULOSIS.pptx
Kampala International University PULMONARY TUBERCULOSIS.pptxYIKIISAAC
 
Paracoccidioidomycosis
ParacoccidioidomycosisParacoccidioidomycosis
ParacoccidioidomycosisSeni MB
 

Similaire à Pulmmonary tuberculosis (20)

Lec 3 tuberculosis 3
Lec 3 tuberculosis 3Lec 3 tuberculosis 3
Lec 3 tuberculosis 3
 
Pathophysiology tubercuslosis
Pathophysiology tubercuslosisPathophysiology tubercuslosis
Pathophysiology tubercuslosis
 
Herd immunity
Herd immunityHerd immunity
Herd immunity
 
Mycobacterium Tuberculosis
Mycobacterium TuberculosisMycobacterium Tuberculosis
Mycobacterium Tuberculosis
 
TUBERCULOSIS pharmacology notes types cure
TUBERCULOSIS pharmacology notes types cureTUBERCULOSIS pharmacology notes types cure
TUBERCULOSIS pharmacology notes types cure
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Infectious disease p3
Infectious disease p3Infectious disease p3
Infectious disease p3
 
Mycobacterium .pptx
Mycobacterium .pptxMycobacterium .pptx
Mycobacterium .pptx
 
Pathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosisPathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosis
 
Immunity against microbial infections dr.ihsan alsaimary
Immunity against microbial infections dr.ihsan alsaimaryImmunity against microbial infections dr.ihsan alsaimary
Immunity against microbial infections dr.ihsan alsaimary
 
TUBERCULOSIS
TUBERCULOSISTUBERCULOSIS
TUBERCULOSIS
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
 
TUBERCOLOSIS and Primary infections.pptx
TUBERCOLOSIS and Primary infections.pptxTUBERCOLOSIS and Primary infections.pptx
TUBERCOLOSIS and Primary infections.pptx
 
1. mycobacterial infection tuberculosis- dr. sinhasan, mdzah
1. mycobacterial infection tuberculosis- dr. sinhasan, mdzah1. mycobacterial infection tuberculosis- dr. sinhasan, mdzah
1. mycobacterial infection tuberculosis- dr. sinhasan, mdzah
 
Mycobacterium Tuberculosis
Mycobacterium TuberculosisMycobacterium Tuberculosis
Mycobacterium Tuberculosis
 
Kampala International University PULMONARY TUBERCULOSIS.pptx
Kampala International University PULMONARY TUBERCULOSIS.pptxKampala International University PULMONARY TUBERCULOSIS.pptx
Kampala International University PULMONARY TUBERCULOSIS.pptx
 
Paracoccidioidomycosis
ParacoccidioidomycosisParacoccidioidomycosis
Paracoccidioidomycosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis.pptx
Tuberculosis.pptxTuberculosis.pptx
Tuberculosis.pptx
 
TUBERCULOSIS (TB)1.pptx
TUBERCULOSIS (TB)1.pptxTUBERCULOSIS (TB)1.pptx
TUBERCULOSIS (TB)1.pptx
 

Pulmmonary tuberculosis

  • 2. Causative agent (P.T.) • : Mycobacterium tuberculosis • Was an important cause of death prior the antibiotic era • Currently its importance rising again due to - AIDS • - multidrug resistance
  • 3. Etiology and Pathogenesis (PT) • M. tuberculosis: transmitted by infective droplets • M. bovis: milk diseased cow • M. avium :  avirulent to normal subjects • M. intracellulare:  disseminated infection in 15-24% AIDS patients
  • 4. Pathogenesis • Mycobacterium - has no known exotoxin, endotoxin, proteolytic enzyme • Pathogenecity of M. tubeculosa is related to ability to: 1. escape killing by macrophages 2. induce delayed hypersensitivity
  • 5. Pathogenesis • Induction of delayed hypersensitivity by P.T. attributed to several components of M. tubersulosa cell wall: 1. cord factor: surface glycolipid, facilitates cultured mycobacter to grow in cords. a. Pathogenic mycobacter: cord factor positive, Non-pathogenic: cord factor negative: Injection purified cord factor in mice ⇒ granuloma formation 2. Lipoarabimannam (LAM): heteropolysaccharide similar to endotoxin in gram negative bacteria.
  • 6. Pathogenesis LAM a. - inhibits macrophage activation by interferon-γ – b. induces macrophages to secrete TNF-α (fever, weight loss, tissue damage) c. induces macrophages to secrete IL-10 suppresses mycobacteria-nduced T-cell proliferation)
  • 7. Pathogenesis • iii. Complement -activated on surface of mycobacteria may opsonise mycobacteria ⇒ macrophage complement receptor (CR3) (Mac-1 integrin) without triggering the respiratory burst necessary to kill the bacteria. iv. Highly immunogenic Tuberculous heat- shock protein is similar to human ⇒ autoimmune reactions induced by mycobacteria.
  • 8. Pathogenesis • Mycobacter resides in phagosomes which are not acidified into lysosomes. • Inhibition of acidification is associated with urease secreted by mycobacter. • The development of cell-mediated, type IV, hypersensitivity to the mycobacteria explains the organism’s destructiveness in tissues and also the emergence of resistance the mycroorganism.
  • 9. Pathogenesis • Initial exposure to the M. tuberculosa ⇒ no-specific inflammatory reaction • After 2-3 weeks: reaction changes to granulomatous, center caseates • The patteren of host response depends on whether the infection is a primary exposure (primary) or it is in a sensitized host (secondary).
  • 10. Primary Tuberculosis • Disease acquired from initial exposure to M. tuberculosa • Inhaled microorganisms multiply in alveoli, alveolar macrophages can not readily kill the bacteria. • Naïve macrophages can not kill mycobacteria ⇒ multiply, lyse the cell ⇒ infect other macrophages, spread by the blood stream.
  • 11. Pathogenesis • After a few weeks (2-3) ⇒ development T- cell-mediated immunity. • Mycobacteria-activated T-cells react with macrophages through following ways: • 1. CD4+ helper T-cells secrete interferon-γ • interferon-γ ⇒ activates macrophages ⇒ killing of intracellular mycobacteria 2. mycobacter through intermediate nitrogen species. ∀ ⇒ epithelioid granuloma formation
  • 12. Pathogenesis 2. CD8+ suppressor T cells ⇒ lyse macrophages infected with mycobacter through Fas-independent pathway. 3. CD4-, CD8- (double-negative) T –cells lyse macrophages by Fas-dependent pathway, without killing mycobacteria.
  • 13. Pathogenesis primary tuberculosis • Mycobacteria can not grow in acidic extracellular environment • ⇒infection is controlled. • Fate of primary tuberculosis: calcification
  • 14. The Ghon Complex: • first lesion of primary tuberculosis • G.C. consists of - peripheral parenchymal granuloma (often located in lower lobes) (Ghon nodule) • a prominent infected mediastinal (hilar) lymphnode • lymphangitis joining nodule to hilar L. node Grossly: Ghon nodule: 1-2 cm ∅
  • 15. Pathogenesis • Histo: Granuloma, central caseous necrosis. • Clinically: Usualy assymptomatic, localized lesions⇒ healing (`~90% cases). • In occasional cases, however, primary tb • - spreads to other parts of the lung (progressive primary TB) common in children, immunocompromised adults
  • 16. Pathogenesis • Gross: primary lesion enlarges to lesions ~6 cm ∅ ⇒ cavities occupying most of lower lobes
  • 17. Secondary TB • This stage results from: • - reactivation of primary pulmonary TB • new infection in a previously sensitized individual • This stage results from: • - reactivation of primary pulmonary TB • new infection in a previously sensitized individual
  • 18. • new infection in a previously sensitized individual • Initial response to M. tuberculosa is different in patients with secondary TB. • Infection ⇒ latent period⇒ cellular immune response ⇒formation of many granulomas , extensive tissue necrosis • Apical and posterior segments upper lobes most commonly affected
  • 19. Histology tuberculous granuloma • Gross: Diffuse fibrotic lesions, with caseative necrosis • ⇒ heal and calcify • ⇒ erosion of bronchi⇒drainage caseous material and infectious agents⇒ tuberculous cavity
  • 20. Tuberculous Cavities • Size: 1- 10 cm • Location: apices of upper lobes • Wall of cavity consists fibrotic material with granulation tissue • Cavity: caseous material with bacilli • On healing: fibrosis with calcifications
  • 21. Complications of secondary tuberculosis 1. milliary TB: presence of multiple, small (size of millet seeds) • granulomas in many organs. • Spread usually haematogenous, mostly from primary pulmonary Tb or from other sites 2.Hemopthysis: Bleeding from eroded blood vessel in cavity ∀ ⇒ Drowning into one’s own blood.
  • 22. Complication tuberculous granuloma 3. Bronchopleural fistula: rupture of subpleural cavity ⇒ pleural • space ⇒ tuberculous empyema ⇒ pneumothorax 4. Intestinal tuberculosis: follows swallowing of tuberculous • material
  • 23. M.tuberculosis and M. avium intracellulare lesions in AIDS • Mycobacterial infection in AIDS can take three forms depending on degree of immunosuppression • 1. In developing countries where M. tuberculosis is frequent: HIV infected individuals have primary and secondary M. tuberculosis infection with the usual well formed granulomas, composed of epithelioid cells, Langerhan’s giant cells and lymphocytes. In these granulomas acid-fast bacilli are few and difficult to find.
  • 24. tuberculosis in AIDS 2. When HIV patients develop AIDS and are moderately immunocompressed (< 200 CD4+ T helper lymphocytes/ml): infection is mostly from reactivation/re-infection. Because mycobacteria infect T-cells and macrophages, defects in the host immune response to M. tuberculosis may be;
  • 25. tuberculosis in AIDS a. secondary to the failure of CD4 helper T-lymphocytes to secrete lymphokines that activate macrophages to kill bacteria b. failure of infected helper T- lymphocytes to secrete and mycobacteria infected macrophages to respond to lymphokines.
  • 26. tuberculosis in AIDS • The relative increase in number of CD8+ cytotoxic T-lymphocytes to cause macrophage destruction in the M. tuberculosa lesions. • ⇒ histologically: granulomas less well formed, are more frequent necrotic, and contain more abundant acid fast bacilli. • Though sputum is positive for mycobacteria in 31-83% of AIDS patients , only 33% react with PPD.
  • 27. tuberculosis in AIDS • extrapulmonary TB occurs in 70% cases involving LN, blood, CNS, and GIT. • 3. Opportunistic infection with M. avium intracellulare (occurs in severely immunocompromised patients: < 60 CD+ T- lymphocytes) Most organisms originate from GIT though some from RT • Infection usually widely disseminated throughout the reticulo-endothelial system ⇒ enlargement of lymphnodes
  • 28. tuberculosis in AIDS • There is a large number of mycobacteria in the enlarged nodes. • Granulomas, lymphocytes and tissue destruction are rare